PRESS RELEASE published on 03/28/2023 at 18:37, 1 year 5 months ago EQS-Adhoc: Wienerberger AG: ADHOC / Wienerberger resolves on new share buyback program
PRESS RELEASE published on 03/27/2023 at 08:30, 1 year 5 months ago Wienerberger AG: We care for a better tomorrow – Wienerberger’s 2022 Annual and Sustainability Report published online
PRESS RELEASE published on 02/27/2023 at 13:00, 1 year 6 months ago Wienerberger AG: Wienerberger AG: Wienerberger grows portfolio for façade solutions in Northern Europe
PRESS RELEASE published on 02/22/2023 at 07:00, 1 year 6 months ago Wienerberger AG: Wienerberger posts strong organic growth in 2022
PRESS RELEASE published on 01/31/2023 at 10:00, 1 year 7 months ago Wienerberger AG: Brick Award 24: Submission started
PRESS RELEASE published on 01/11/2023 at 10:00, 1 year 8 months ago Wienerberger AG: Wienerberger commits to forward-looking and sustainable energy management across the Group
Published on 09/20/2024 at 23:40, 5 hours 46 minutes ago Integrated BioPharma Reports Results for Its Quarter and Fiscal Year Ended June 30, 2024
Published on 09/20/2024 at 23:30, 5 hours 56 minutes ago Final Bell Holdings International Ltd. Announces Sale of Final Bell Corp.
Published on 09/20/2024 at 23:00, 6 hours 26 minutes ago AI/ML Innovations Inc. Provides Second Status Update
Published on 09/20/2024 at 22:30, 6 hours 56 minutes ago Electric Metals Announces Changes to its Board of Directors
Published on 09/20/2024 at 22:15, 7 hours 11 minutes ago Torq Clarifies Finder’s Warrant Exercise Price of $0.10 Financing
Published on 09/20/2024 at 22:58, 6 hours 27 minutes ago Freelance.com: Mise à disposition du Document d’Enregistrement Universel 2023
Published on 09/20/2024 at 21:00, 8 hours 26 minutes ago Aurubis celebrates ribbon-cutting at the first multimetal recycling plant in the United States
Published on 09/20/2024 at 20:14, 9 hours 11 minutes ago EQS-Adhoc: GRAMMER AG sells TMD Group in North America
Published on 09/20/2024 at 19:50, 9 hours 36 minutes ago BRAIN Biotech AG concludes major pharma compound transaction valued up to EUR 128.88 million from its BioIncubator
Published on 09/20/2024 at 19:47, 9 hours 39 minutes ago EQS-Adhoc: BRAIN Biotech AG concludes royalty monetization deal for up to EUR 128.88 million on investigational pharma compound deucrictibant with Royalty Pharma
Published on 09/20/2024 at 17:40, 11 hours 46 minutes ago Availability of the 2024 Half-Year Financial Report
Published on 09/20/2024 at 17:40, 11 hours 46 minutes ago Mise à disposition du Rapport Financier Semestriel 2024